Key facts
- This page summarizes Dino A. Rossi's Form 4 filing for Krystal Biotech, Inc. (KRYS).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 Feb 2026, 19:14.
Dino A. Rossi - 19 Feb 2026 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)
- Reporting relationship
- Director
- Issuer ticker
- KRYS
- Reported as of
- 19 Feb 2026
- Net transaction value
- -$4,787,124
- SEC form
- 4
- Accepted by SEC
- 23 Feb 2026, 19:14:37 UTC
- Prior SEC filing
- 30 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Krish Krishnan, as attorney-in-fact for Dino A. Rossi
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Dino A. Rossi filed Form 4 for Krystal Biotech, Inc. (KRYS) on 23 Feb 2026.
Change
- Previous filing in this sequence was filed on 30 Jun 2025.
- Current net transaction value: -$4,787,124.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001209059
Primary reporting owner
ROSSI DINO A
- Relationship
- Director
- Address
- C/O KRYSTAL BIOTECH, INC., 2100 WHARTON STREET, SUITE 701, PITTSBURGH
- Signature
- /s/ Krish Krishnan, as attorney-in-fact for Dino A. Rossi
- Signature date
- 23 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KRYS
transaction
Common Stock
Options Exercise
- Transaction value
- $166,570
- Shares
- +18,950
- Change %
- +24%
- Price
- $8.79
- Shares after
- 97,641
- Date
- 19 Feb 2026
- Ownership
- Direct
KRYS
transaction
Common Stock
Sale
- Transaction value
- $2,114,103
- Shares
- -8,116
- Change %
- -8.3%
- Price
- $260.49
- Shares after
- 89,525
- Date
- 19 Feb 2026
- Ownership
- Direct
KRYS
transaction
Common Stock
Sale
- Transaction value
- $2,839,591
- Shares
- -10,834
- Change %
- -12%
- Price
- $262.10
- Shares after
- 78,691
- Date
- 19 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KRYS
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -18,950
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 19 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,950
- Exercise price
- $8.79
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Multiple lots for the same price for this transaction have been combined.
Footnote F2
The options vested ratably over a four-year period beginning on June 1, 2018.